Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2014 Jan 21; 129(3):293-303.

View in: PubMed

subject areas

Acute Coronary Syndrome
Adenosine
Biomarkers
Electrocardiography
Growth Differentiation Factor 15
Hospital Mortality
Humans
Kaplan-Meier Estimate
Myocardial Revascularization
Natriuretic Peptide, Brain
Peptide Fragments
Predictive Value of Tests
Prognosis
Prospective Studies
Purinergic P2Y Receptor Antagonists
Risk Factors
Ticlopidine
Troponin T

authors with profiles

Robert Harrington